Warning letter
ChemPacific Corporation [ARCHIVED]: warning letter of Apr 7, 2011
FDA warning letter 150412 · Baltimore District Office
Key facts
| Reference number | 150412 |
|---|---|
| Company | ChemPacific Corporation [ARCHIVED] |
| Subject | CGMP for Active Pharmaceutical Ingredient (API)/Adulterated |
| Issue date | Apr 7, 2011 |
| Posted date | Apr 7, 2011 |
| Issuing office | Baltimore District Office |
| Product type | Drugs |
| Inspection city | Baltimore |
| Inspection ZIP | 21224 |
| Inspection start date | Sep 27, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: